Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance

European Journal of Pediatrics

Volumn 158, Issue 6, 1999, Pages 455-459

  Kentrup, H ^a   Bongers, H ^a   Spengler, M ^b   Kusenbach, G ^a   Skopnik, H ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b BAYER AG   (Germany)

^c Kinderklinik   (Germany)

Author keywords

Acarbose; Cystic fibrosis; Diabetes mellitus; Impaired glucose tolerance

Indexed keywords

ACARBOSE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL TOXICITY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ACARBOSE; ADOLESCENT; ADULT; ALPHA-GLUCOSIDASES; BLOOD GLUCOSE; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; TRISACCHARIDES;

EID: 0032970094     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051119     Document Type: Article

References (18)

1. 1. American Diabetes Association (1998) Clinical practice recommendations 1998. Diabetes Care 21 [Suppl 1]:5-20
2. 2. Balfour JA, McTavish D (1993) Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025-1054
3. 3. Braun D, Schönherr U, Mitzkat H-J (1996) Efficacy of acarbose monotherapy in patients with type 2 diabetes: a double-blind study conducted in general practice. Endocrinol Metab 3:275-280
4. 4. Clissold SP, Edwards C (1988) Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35:214-243
5. 5. Coniff RF, Shapiro JA, Seaton TB, Bray GA (1995) Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med 98:443-451
6. 6. Couet C, Ulmer M, Hamdaoui M, Bau HM, Debry G (1989) Metabolic effects of acarbose in young healthy men. Eur J Clin Nutr 43:187-196
7. 7. De Schepper J, Dab I, Derde MP, Loeb H (1991) Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations. Eur J Pediatr 150:403-406
8. 8. De Schepper J, Hachimi Idrissi S, Smitz J, Dab I, Loeb H (1992) First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res 38:260-263
9. 9. Frase LL, Strickland D, Kachel GW, Krejs GJ (1985) Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology 88:478-484
10. 10. Hanefeld M (1998) The role of acarbose in NIDDM. J Diabetes Complications 12:228-237
11. 11. Hartling SG, Game S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C (1988) Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test. Diabetes Res 7:165-169
12. 12. Holl RW, Heinze E, Wolf A, Rank M, Teller WM (1995) Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 154:356-361
13. 13. Krueger LJ, Lerner A, Katz SM, Mack R, Holsclaw DS Jr, Lebenthal E (1991) Cystic fibrosis and diabetes mellitus: interactive or idiopathic? J Pediatr Gastroenterol Nutr 13:209-219
14. 14. Lanng S, Thorsteinsson B, Lund Andersen C, Nerup J, Schiotz PO, Koch C (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83:72-77
15. 15. Lanng S, Thorsteinsson B, Nerup J, Koch C (1994) Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 83:849-853
16. 16. MacDonald A (1996) Nutritional management of cystic fibrosis. Arch Dis Childhood 74:81-87
17. 17. Rodger NW, Chiasson J-L, Josse RG, Hunt JA, Palmason CA, Ross SA, Ryan EA, Tan MH, Wolever TMS (1995) Clinical experience with acarbose: results of a Canadian multicentre study. Clin Invest Med 18:318-324
18. 18. Skopnik H, Kentrup H, Kusenbach G, Pfäffle R, Kock R (1993) Glukosehomöostase bei Zystischer Fibrose: Oraler Glukosetoleranztest im Vergleich zu einer Formulabelastung. Monatsschrift Kinderheilkunde 141:42-47